Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 4 institutions in 3 countries.
Gina Kruse *Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts, USA gkruse@mgh.harvard.edu.ORCID 0000-0002-6681-220X
Thando Zulu *Africa Health Research Institute, Durban, Kwa-Zulu Natal, South Africa.
Hloniphile Ngubane *Africa Health Research Institute, Durban, Kwa-Zulu Natal, South Africa.
Krishna ReddyTobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Mark SiednerHarvard Medical School, Boston, Massachusetts, USA.
Nancy A RigottiTobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Janet SeeleyDepartment of Global Health & Development, London School of Hygiene and Tropical Medicine, London, UK.
Nothando NgwenyaAfrica Health Research Institute, Durban, Kwa-Zulu Natal, South Africa.
Emily WongAfrica Health Research Institute, Durban, Kwa-Zulu Natal, South Africa.
Harvard University · USAfrica Health Research Institute · ZALondon School of Hygiene & Tropical Medicine · GBUniversity of Alabama at Birmingham · US
Funding
Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes (Clinical and public health approaches to tobacco cessation in South Africa supplement)R01DA050482 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI REDDY, KRISHNA P · 2020 to 2024
$3.4M
NIDA NIH HHS R01 DA050482
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
HumansSouth AfricaTobacco ProductsHealth policies and all other topics
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The ethics of conducting observational tobacco research without providing treatment to people who use tobacco: a case example from South Africa. · full record | OpenQuestion